KURA
Kura Oncology, Inc.
Company overview
- Market capitalization
- $943.87M
- Employees
- 260
- Latest publication
- 2026-09-29
About Kura Oncology, Inc.
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 20,874,000USD | 18,265,000USD | 17,336,000USD | 15,288,000USD | 14,108,000USD | 53,883,000USD | 0USD | 0USD |
| Cost Of Revenue | 243,000USD | 617,000USD | 460,000USD | 224,000USD | 0USD | 204,000USD | 208,000USD | 202,000USD |
| Gross Profit | 20,631,000USD | 17,648,000USD | 17,336,000USD | 15,288,000USD | 14,108,000USD | 53,883,000USD | -208,000USD | -202,000USD |
| Research Development | 61,891,000USD | 65,263,000USD | 64,408,000USD | 62,785,000USD | 55,973,000USD | 52,267,000USD | 41,705,000USD | 39,727,000USD |
| Selling General Administrative | 31,750,000USD | 31,555,000USD | 39,139,000USD | 25,169,000USD | 22,835,000USD | 24,071,000USD | 18,179,000USD | 16,677,000USD |
| Total Operating Expenses | 93,641,000USD | 96,463,000USD | 103,604,000USD | 87,954,000USD | 78,808,000USD | 76,338,000USD | 59,884,000USD | 56,202,000USD |
| Operating Income | -73,010,000USD | -78,815,000USD | -86,268,000USD | -72,666,000USD | -64,700,000USD | -22,455,000USD | -59,884,000USD | -56,404,000USD |
| Total Other Income Expense Net | 4,688,000USD | 5,490,000USD | 5,340,000USD | 6,544,000USD | 7,497,000USD | 5,256,000USD | 5,480,000USD | 5,567,000USD |
| Interest Expense | 345,000USD | 336,000USD | 346,000USD | 391,000USD | 382,000USD | 403,000USD | 412,000USD | 406,000USD |
| Income Before Tax | -68,322,000USD | -73,325,000USD | -80,928,000USD | -66,122,000USD | -57,203,000USD | -17,199,000USD | -54,404,000USD | -50,837,000USD |
| Income Tax Expense | 5,000USD | 8,000USD | 71,000USD | — | 226,000USD | 2,018,000USD | — | — |
| Net Income | -68,327,000USD | -73,333,000USD | -80,999,000USD | -66,122,000USD | -57,429,000USD | -19,217,000USD | -54,404,000USD | -50,837,000USD |
| Interest Income | — | 5,826,000USD | 5,686,000USD | 6,935,000USD | 7,879,000USD | 5,659,000USD | 5,892,000USD | 5,973,000USD |
| Net Interest Income | — | 5,490,000USD | 5,340,000USD | 6,544,000USD | 7,497,000USD | 5,256,000USD | 5,480,000USD | 5,567,000USD |
| Tax Provision | — | 8,000USD | 71,000USD | 0USD | 226,000USD | — | — | 0USD |
| Net Income From Continuing Ops | — | -73,333,000USD | -80,999,000USD | -66,122,000USD | -57,429,000USD | -19,217,000USD | -54,404,000USD | -50,837,000USD |
| Ebit | — | -72,989,000USD | -80,582,000USD | -65,731,000USD | -57,585,000USD | -16,796,000USD | -53,992,000USD | -50,431,000USD |
| Ebitda | — | -72,634,000USD | -80,179,000USD | -65,507,000USD | -57,344,000USD | -16,592,000USD | -53,784,000USD | -50,229,000USD |
| Depreciation And Amortization | — | 355,000USD | 403,000USD | 224,000USD | 241,000USD | 204,000USD | 208,000USD | 202,000USD |
| Reconciled Depreciation | — | 355,000USD | 403,000USD | 224,000USD | 241,000USD | 204,000USD | 208,000USD | 202,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 202,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 67,482,000USD | 53,883,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 57,000USD | 848,000USD | 849,000USD | 759,000USD | 558,000USD | 194,000USD | 30,000USD | 31,000USD |
| Gross Profit | 67,425,000USD | 53,883,000USD | -849,000USD | -759,000USD | -558,000USD | -194,000USD | -30,000USD | -31,000USD |
| Research Development | 251,074,000USD | 169,967,000USD | 115,235,000USD | 92,812,000USD | 84,721,000USD | 60,397,000USD | 26,426,000USD | 20,404,000USD |
| Selling General Administrative | 119,982,000USD | 77,111,000USD | 50,569,000USD | 47,053,000USD | 46,537,000USD | 31,308,000USD | 9,651,000USD | 7,963,000USD |
| Total Operating Expenses | 371,056,000USD | 247,078,000USD | 164,955,000USD | 139,865,000USD | 131,258,000USD | 91,705,000USD | 36,077,000USD | 28,367,000USD |
| Operating Income | -303,631,000USD | -193,195,000USD | -165,804,000USD | -139,865,000USD | -131,258,000USD | -91,899,000USD | -36,077,000USD | -28,367,000USD |
| Interest Income | 26,774,000USD | 22,849,000USD | 12,623,000USD | 4,254,000USD | 1,206,000USD | 2,801,000USD | 751,000USD | 499,000USD |
| Interest Expense | 1,512,000USD | 1,619,000USD | 1,549,000USD | 229,000USD | 414,000USD | 578,000USD | 888,000USD | 577,000USD |
| Net Interest Income | 25,262,000USD | 21,230,000USD | 11,239,000USD | 4,025,000USD | 792,000USD | 2,223,000USD | -137,000USD | -78,000USD |
| Income Before Tax | -278,369,000USD | -171,965,000USD | -152,631,000USD | -135,840,000USD | -130,466,000USD | -89,625,000USD | -35,434,000USD | -27,560,000USD |
| Income Tax Expense | 297,000USD | 2,018,000USD | — | 229,000USD | -558,000USD | -194,000USD | -30,000USD | -31,000USD |
| Tax Provision | 297,000USD | 2,018,000USD | 0USD | 0USD | — | — | — | — |
| Net Income | -278,666,000USD | -173,983,000USD | -152,631,000USD | -135,840,000USD | -130,466,000USD | -89,625,000USD | -35,434,000USD | -27,560,000USD |
| Net Income From Continuing Ops | -278,666,000USD | -173,983,000USD | -142,959,000USD | -135,840,000USD | -130,466,000USD | -89,625,000USD | -35,434,000USD | -27,560,000USD |
| Ebit | -276,857,000USD | -170,346,000USD | -151,082,000USD | -135,611,000USD | -130,052,000USD | -89,047,000USD | -36,077,000USD | -28,367,000USD |
| Ebitda | -275,825,000USD | -169,498,000USD | -150,233,000USD | -134,852,000USD | -129,494,000USD | -88,853,000USD | -36,047,000USD | -28,336,000USD |
| Depreciation And Amortization | 1,032,000USD | 848,000USD | 849,000USD | 759,000USD | 558,000USD | 194,000USD | 30,000USD | 31,000USD |
| Reconciled Depreciation | 1,032,000USD | 848,000USD | 841,000USD | 759,000USD | 558,000USD | 194,000USD | 30,000USD | — |
| Total Other Income Expense Net | 25,262,000USD | 21,230,000USD | 13,173,000USD | 4,025,000USD | 792,000USD | 2,274,000USD | 643,000USD | 807,000USD |
| Non Operating Income Net Other | — | — | — | 4,254,000USD | 1,206,000USD | 2,852,000USD | 1,531,000USD | 807,000USD |
| Net Income Applicable To Common Shares | — | — | — | -135,840,000USD | -130,466,000USD | -89,625,000USD | -35,434,000USD | -27,560,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 587,791,000USD | 652,551,000USD | 738,363,000USD | 649,381,000USD | 682,425,000USD | 743,764,000USD | 760,159,000USD | 478,837,000USD |
| Cash And Equivalents | 70,242,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 559,439,000USD | 623,782,000USD | 708,663,000USD | 620,663,000USD | 660,075,000USD | 724,198,000USD | 744,829,000USD | 463,189,000USD |
| Other Current Assets | 28,483,000USD | 28,468,000USD | 28,406,000USD | 31,762,000USD | 24,773,000USD | 17,261,000USD | 17,434,000USD | 7,892,000USD |
| Other Non Current Assets | 13,728,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 539,360,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 118,193,000USD | 101,496,000USD | 116,974,000USD | 121,304,000USD | 107,174,000USD | 89,766,000USD | 78,712,000USD | 40,372,000USD |
| Other Non Current Liabilities | 3,616,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 48,431,000USD | 107,883,000USD | 174,135,000USD | 242,542,000USD | 305,486,000USD | 364,406,000USD | 413,640,000USD | 423,771,000USD |
| Total Equity Including Noncontrolling Interest | 48,431,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 4,217,000USD | — | — | 4,337,000USD | 3,112,000USD | 1,921,000USD | 2,607,000USD | 1,715,000USD |
| Long Term Debt | 5,573,000USD | 9,749,000USD | 9,711,000USD | 5,336,000USD | 6,509,000USD | 7,650,000USD | 6,916,000USD | 7,757,000USD |
| Deferred Revenue | 55,481,000USD | — | — | — | — | — | — | — |
| Deferred Revenue Non Current | 398,604,000USD | — | — | — | — | — | — | — |
| Net Receivables | 9,446,000USD | 13,648,000USD | 12,604,000USD | 39,236,000USD | 4,574,000USD | 48,746,000USD | 6,100,000USD | — |
| Inventory | 2,485,000USD | 843,000USD | 413,000USD | — | — | — | 0USD | — |
| Property Plant Equipment Net | 14,624,000USD | 14,779,000USD | 15,157,000USD | 14,936,000USD | 11,776,000USD | 10,487,000USD | 7,485,000USD | 7,415,000USD |
| Accounts Payable | 2,392,000USD | 7,043,000USD | 5,017,000USD | 4,671,000USD | 1,704,000USD | 4,610,000USD | 1,469,000USD | 3,006,000USD |
| Short Term Debt | 1,291,000USD | 1,283,000USD | 1,277,000USD | 5,766,000USD | 4,808,000USD | 3,826,000USD | 4,488,000USD | 3,406,000USD |
| Common Stock | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 8,000USD | 8,000USD | 8,000USD |
| Retained Earnings | -1,315,748,000USD | -1,247,421,000USD | -1,174,088,000USD | -1,093,089,000USD | -1,018,973,000USD | -952,851,000USD | -895,422,000USD | -876,205,000USD |
| Total Liab | — | 544,668,000USD | 564,228,000USD | 406,839,000USD | 376,939,000USD | 379,358,000USD | 346,519,000USD | 55,066,000USD |
| Other Current Liab | — | 45,466,000USD | 61,697,000USD | 62,117,000USD | 51,227,000USD | 38,197,000USD | 46,423,000USD | 33,960,000USD |
| Capital Stock | — | 9,000USD | 9,000USD | 9,000USD | 9,000USD | 8,000USD | 8,000USD | 8,000USD |
| Cash | — | 39,083,000USD | 149,099,000USD | 95,287,000USD | 81,948,000USD | 51,269,000USD | 224,462,000USD | 49,480,000USD |
| Cash And Short Term Investments | — | 580,823,000USD | 667,240,000USD | 549,665,000USD | 630,728,000USD | 658,191,000USD | 727,395,000USD | 455,297,000USD |
| Current Deferred Revenue | — | 47,704,000USD | 48,983,000USD | 48,750,000USD | 49,435,000USD | 40,846,000USD | 24,271,000USD | — |
| Net Debt | — | -14,810,000USD | -128,642,000USD | -75,821,000USD | -62,475,000USD | -31,915,000USD | -207,868,000USD | -32,851,000USD |
| Short Long Term Debt Total | — | 24,273,000USD | 20,457,000USD | 19,466,000USD | 19,473,000USD | 19,354,000USD | 16,594,000USD | 16,629,000USD |
| Short Term Investments | — | 541,740,000USD | 518,140,999USD | 454,378,000USD | 548,780,000USD | 606,922,000USD | 502,933,000USD | 405,817,000USD |
| Property Plant Equipment Gross | — | 18,020,000USD | 18,057,000USD | 18,804,000USD | 15,516,000USD | 14,003,000USD | 10,760,000USD | 10,485,000USD |
| Accumulated Other Comprehensive Income | — | -380,000USD | 1,024,000USD | 918,000USD | 711,000USD | 974,000USD | 764,000USD | 1,116,000USD |
| Common Stock Shares Outstanding | — | 88,610,000shares | 88,050,000shares | 87,645,000shares | 87,586,000shares | 87,415,000shares | 87,136,000shares | 86,950,000shares |
| Non Current Assets Total | — | 28,769,000USD | 29,700,000USD | 28,718,000USD | 22,350,000USD | 19,566,000USD | 15,330,000USD | 15,648,000USD |
| Non Current Liabilities Total | — | 443,172,000USD | 447,254,000USD | 285,534,999USD | 269,765,000USD | 289,592,000USD | 267,807,000USD | 14,694,000USD |
| Non Current Liabilities Other | — | 3,437,000USD | 3,165,000USD | 2,981,000USD | 2,595,000USD | 2,139,000USD | 1,795,000USD | 1,471,000USD |
| Non Currrent Assets Other | — | 13,990,000USD | 14,543,000USD | 13,782,000USD | 10,574,000USD | 9,079,000USD | 7,845,000USD | 8,233,000USD |
| Net Working Capital | — | 522,286,000USD | 591,689,000USD | 499,359,000USD | 552,901,000USD | 634,432,000USD | 666,117,000USD | 422,817,000USD |
| Unclassified Non Current Liabilities | — | 429,986,000USD | 434,378,000USD | 277,217,999USD | 260,661,000USD | 279,803,000USD | 259,096,000USD | 5,466,000USD |
| Unclassified Equity | — | 1,355,666,000USD | 1,347,181,000USD | 1,334,695,000USD | 1,323,730,000USD | 1,316,267,000USD | 1,308,282,000USD | 1,298,844,000USD |
| Unclassified Current Liabilities | — | — | — | -4,337,000USD | -3,112,000USD | — | — | -1,715,000USD |
| Other Assets | — | — | — | — | — | — | -280,516,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 738,363,000USD | 760,159,000USD | 448,935,000USD | 456,306,000USD | 534,051,000USD | 647,212,000USD | 241,972,000USD | 182,379,000USD |
| Other Current Assets | 28,406,000USD | 17,434,000USD | 8,524,000USD | 8,441,000USD | 4,329,000USD | 3,972,000USD | 2,682,000USD | 3,976,000USD |
| Total Liab | 564,228,000USD | 346,519,000USD | 51,662,000USD | 36,028,000USD | 27,442,000USD | 36,307,000USD | 23,191,000USD | 21,394,000USD |
| Total Stockholder Equity | 174,135,000USD | 413,640,000USD | 397,273,000USD | 420,278,000USD | 506,609,000USD | 610,905,000USD | 218,781,000USD | 160,985,000USD |
| Other Current Liab | 61,697,000USD | 46,423,000USD | 31,457,000USD | 20,206,000USD | 16,956,000USD | 18,182,000USD | 11,536,000USD | 9,680,000USD |
| Common Stock | 9,000USD | 8,000USD | 7,000USD | 7,000USD | 7,000USD | 7,000USD | 5,000USD | 4,000USD |
| Capital Stock | 9,000USD | 8,000USD | 7,000USD | 7,000USD | 7,000USD | 7,000USD | 5,000USD | 4,000USD |
| Retained Earnings | -1,174,088,000USD | -895,422,000USD | -721,439,000USD | -568,808,000USD | -432,968,000USD | -302,502,000USD | -212,877,000USD | -149,737,000USD |
| Cash | 149,099,000USD | 224,462,000USD | 37,318,000USD | 51,802,000USD | 90,672,000USD | 325,493,000USD | 26,135,000USD | 16,119,000USD |
| Cash And Short Term Investments | 667,240,000USD | 727,395,000USD | 423,957,000USD | 437,985,000USD | 517,960,000USD | 633,320,000USD | 236,891,000USD | 178,985,000USD |
| Total Current Assets | 708,663,000USD | 744,829,000USD | 432,481,000USD | 446,426,000USD | 522,289,000USD | 637,292,000USD | 239,603,000USD | 181,197,000USD |
| Total Current Liabilities | 116,974,000USD | 78,712,000USD | 35,263,000USD | 24,057,000USD | 22,455,000USD | 26,024,000USD | 15,564,000USD | 13,615,000USD |
| Current Deferred Revenue | 48,983,000USD | 24,271,000USD | — | — | — | — | — | — |
| Net Debt | -128,642,000USD | -207,868,000USD | -20,118,000USD | -37,778,000USD | -83,797,000USD | -310,516,000USD | -18,383,000USD | -8,619,000USD |
| Short Term Debt | 1,277,000USD | 4,488,000USD | 1,506,000USD | 2,318,000USD | 2,263,000USD | 5,089,000USD | 502,000USD | — |
| Short Long Term Debt Total | 20,457,000USD | 16,594,000USD | 17,200,000USD | 14,024,000USD | 6,875,000USD | 14,977,000USD | 7,752,000USD | 7,500,000USD |
| Long Term Debt | 9,711,000USD | 6,916,000USD | 9,332,000USD | 9,158,000USD | — | 4,250,000USD | 7,250,000USD | 7,500,000USD |
| Short Term Investments | 518,141,000USD | 502,933,000USD | 386,639,000USD | 386,183,000USD | 427,288,000USD | 307,827,000USD | 210,756,000USD | 162,866,000USD |
| Net Receivables | 12,604,000USD | 6,100,000USD | 2,800,000USD | 900,000USD | 1,400,000USD | — | 30,000USD | 224,000USD |
| Inventory | 413,000USD | 0USD | — | — | — | — | — | — |
| Accounts Payable | 5,017,000USD | 1,469,000USD | 2,300,000USD | 1,533,000USD | 3,236,000USD | 2,753,000USD | 3,526,000USD | 3,935,000USD |
| Property Plant Equipment Net | 15,157,000USD | 7,485,000USD | 8,852,000USD | 6,382,000USD | 8,246,000USD | 8,355,000USD | 278,000USD | — |
| Property Plant Equipment Gross | 18,057,000USD | 10,760,000USD | 11,304,000USD | 7,985,000USD | 9,090,000USD | 8,355,000USD | 44,000USD | — |
| Accumulated Other Comprehensive Income | 1,024,000USD | 764,000USD | -1,271,000USD | -8,032,000USD | -1,789,000USD | 46,000USD | 331,000USD | -131,000USD |
| Common Stock Shares Outstanding | 87,676,000shares | 86,161,000shares | 73,229,000shares | 66,990,000shares | 66,352,000shares | 53,077,000shares | 41,946,000shares | 35,191,000shares |
| Non Current Assets Total | 29,700,000USD | 15,330,000USD | 16,454,000USD | 9,880,000USD | 11,762,000USD | 9,920,000USD | 2,369,000USD | 1,182,000USD |
| Non Current Liabilities Total | 447,254,000USD | 267,807,000USD | 16,399,000USD | 11,971,000USD | 4,987,000USD | 10,283,000USD | 7,627,000USD | 7,779,000USD |
| Non Current Liabilities Other | 3,165,000USD | 1,795,000USD | 705,000USD | 265,000USD | 4,987,000USD | 6,033,000USD | 377,000USD | 279,000USD |
| Non Currrent Assets Other | 14,543,000USD | 7,845,000USD | 7,602,000USD | 3,498,000USD | 3,516,000USD | 1,565,000USD | 2,091,000USD | 1,182,000USD |
| Net Working Capital | 591,689,000USD | 666,117,000USD | 397,218,000USD | 422,369,000USD | 499,834,000USD | 611,268,000USD | 224,039,000USD | 167,582,000USD |
| Unclassified Non Current Liabilities | 434,378,000USD | 259,096,000USD | 6,362,000USD | 2,283,000USD | — | — | — | — |
| Unclassified Equity | 1,347,181,000USD | 1,308,282,000USD | 1,119,969,000USD | 997,104,000USD | 941,352,000USD | 913,347,000USD | 431,317,000USD | 310,845,000USD |
| Short Long Term Debt | — | 2,607,000USD | — | — | — | 3,000,000USD | 250,000USD | — |
| Other Liab | — | — | — | 265,000USD | 375,000USD | 395,000USD | 377,000USD | 279,000USD |
| Other Assets | — | — | — | 3,498,000USD | 3,516,000USD | 7,899,000USD | 2,091,000USD | 1,182,000USD |
| Net Tangible Assets | — | — | — | 420,278,000USD | 506,609,000USD | 610,905,000USD | 218,781,000USD | 160,985,000USD |
| Unclassified Non Current Assets | — | — | — | -3,498,000USD | -3,516,000USD | -7,899,000USD | -2,091,000USD | -1,182,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | -3,000,000USD | — | — |
| Unclassified Current Assets | — | — | — | — | — | — | — | -1,988,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -73,333,000USD | -80,999,000USD | -74,116,000USD | -66,122,000USD | -57,429,000USD | -19,217,000USD | -54,404,000USD | -50,837,000USD |
| Depreciation | 355,000USD | 1,683,000USD | 164,000USD | 224,000USD | 241,000USD | 204,000USD | 208,000USD | 202,000USD |
| Stock Based Compensation | 8,416,000USD | 11,352,000USD | 10,965,000USD | 6,949,000USD | 7,842,000USD | 8,631,000USD | 8,324,000USD | 8,430,000USD |
| Other Non Cash Items | -794,000USD | -2,559,000USD | 26,597,000USD | -5,688,001USD | -2,529,000USD | -2,745,000USD | 2,373,000USD | -3,422,000USD |
| Change To Account Receivables | -544,000USD | 27,132,000USD | -31,362,000USD | 44,172,000USD | -46,686,000USD | — | — | 0USD |
| Change To Inventory | -430,000USD | — | — | — | 0USD | — | — | — |
| Change In Working Capital | -20,498,000USD | 187,796,000USD | -44,237,000USD | 35,860,001USD | -20,052,000USD | 282,258,000USD | 59,000USD | 3,097,000USD |
| Total Cash From Operating Activities | -85,854,000USD | 117,273,000USD | -80,627,000USD | -28,777,000USD | -71,927,000USD | 269,131,000USD | -43,440,000USD | -42,530,000USD |
| Capital Expenditures | -128,000USD | -2,321,000USD | -2,567,000USD | -1,458,000USD | -292,000USD | -372,000USD | 0USD | -16,000USD |
| Free Cash Flow | -85,982,000USD | 114,952,000USD | -83,193,999USD | -30,235,000USD | -72,219,000USD | 268,759,000USD | -43,440,000USD | -42,546,000USD |
| Investments | -24,103,000USD | -62,275,000USD | 93,966,000USD | 58,941,000USD | -101,409,000USD | -94,955,000USD | 45,535,000USD | 43,167,000USD |
| Total Cashflows From Investing Activities | -24,231,000USD | -64,596,000USD | 93,966,000USD | 58,941,000USD | -101,409,000USD | -94,955,000USD | 45,535,000USD | 43,167,000USD |
| Total Cash From Financing Activities | 69,000USD | 1,135,000USD | 0USD | 515,000USD | 143,000USD | 806,000USD | 2,202,000USD | 3,040,000USD |
| Change In Cash | -110,016,000USD | 53,812,000USD | 13,339,000USD | 30,679,000USD | -173,193,000USD | 174,982,000USD | 4,297,000USD | 3,677,000USD |
| Begin Period Cash Flow | 149,099,000USD | 95,287,000USD | 81,948,000USD | 51,269,000USD | 224,462,000USD | 49,480,000USD | 45,183,000USD | 41,506,000USD |
| End Period Cash Flow | 39,083,000USD | 149,099,000USD | 95,287,000USD | 81,948,000USD | 51,269,000USD | 224,462,000USD | 49,480,000USD | 45,183,000USD |
| Issuance Of Capital Stock | — | 0USD | 0USD | 0USD | 0USD | -1,000USD | 0USD | 0USD |
| Unclassified Financing Cash Flow | — | 1,135,000USD | — | — | — | — | — | — |
| Other Cashflows From Investing Activities | — | — | 96,533,000USD | 60,399,000USD | — | — | 45,535,000USD | 43,183,000USD |
| Unclassified Investing Cash Flow | — | — | -93,966,000USD | -58,941,000USD | — | — | -45,535,000USD | -43,167,000USD |
| Other Cashflows From Financing Activities | — | — | — | 515,000USD | 143,000USD | 807,000USD | 2,202,000USD | 3,040,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -278,666,000USD | -173,983,000USD | -152,631,000USD | -135,840,000USD | -130,466,000USD | -89,625,000USD | -63,140,000USD | -60,447,000USD |
| Depreciation | -7,456,000USD | 848,000USD | 849,000USD | 759,000USD | 558,000USD | 194,000USD | -1,103,000USD | 10,000USD |
| Stock Based Compensation | 37,108,000USD | 33,897,000USD | 28,082,000USD | 26,318,000USD | 23,579,000USD | 12,807,000USD | 9,409,000USD | 8,654,000USD |
| Other Non Cash Items | 515,000USD | -12,618,000USD | -8,943,000USD | 1,683,000USD | 399,000USD | 410,000USD | -1,103,000USD | 184,000USD |
| Change To Account Receivables | -6,744,000USD | -2,060,000USD | 0USD | — | — | — | 210,000USD | -8,000USD |
| Change To Inventory | -413,000USD | 0USD | 0USD | — | — | — | -856,000USD | -443,000USD |
| Change In Working Capital | 184,441,000USD | 286,173,000USD | 7,819,000USD | -2,982,000USD | -3,224,000USD | 6,384,000USD | 74,000USD | 4,381,000USD |
| Total Cash From Operating Activities | -64,058,000USD | 134,317,000USD | -124,824,000USD | -110,062,000USD | -104,551,000USD | -69,830,000USD | -54,760,000USD | -48,655,000USD |
| Capital Expenditures | -6,638,000USD | -472,000USD | -168,000USD | -626,000USD | -1,147,000USD | -2,171,000USD | -2,171,000USD | -2,171,000USD |
| Free Cash Flow | -70,696,000USD | 133,845,000USD | -124,992,000USD | -110,688,000USD | -105,698,000USD | -72,001,000USD | -54,760,000USD | -48,655,000USD |
| Investments | -6,460,000USD | -101,590,000USD | -73,956,000USD | 32,627,000USD | -125,688,000USD | -97,765,000USD | -46,325,000USD | -79,300,000USD |
| Total Cashflows From Investing Activities | -13,098,000USD | -101,590,000USD | 15,557,000USD | 32,627,000USD | -126,835,000USD | -99,936,000USD | -46,325,000USD | -79,300,000USD |
| Total Cash From Financing Activities | 1,793,000USD | 154,417,000USD | 94,783,000USD | 38,565,000USD | -3,435,000USD | 469,334,000USD | 111,101,000USD | 132,641,000USD |
| Issuance Of Capital Stock | 0USD | 145,813,000USD | 118,298,000USD | 24,721,000USD | 324,335,000USD | 459,335,000USD | 108,165,000USD | 132,172,000USD |
| Change In Cash | -75,363,000USD | 187,144,000USD | -14,484,000USD | -38,870,000USD | -234,821,000USD | 299,568,000USD | 10,016,000USD | 4,686,000USD |
| Begin Period Cash Flow | 224,462,000USD | 37,318,000USD | 51,802,000USD | 90,882,000USD | 325,703,000USD | 26,135,000USD | 16,119,000USD | 11,433,000USD |
| End Period Cash Flow | 149,099,000USD | 224,462,000USD | 37,318,000USD | 52,012,000USD | 90,882,000USD | 325,703,000USD | 26,135,000USD | 16,119,000USD |
| Unclassified Financing Cash Flow | 1,793,000USD | — | -24,721,000USD | -3,844,000USD | -319,298,000USD | — | — | — |
| Net Borrowings | — | 0USD | 0USD | 9,425,000USD | -7,861,000USD | -250,000USD | -250,000USD | -623,000USD |
| Other Cashflows From Financing Activities | — | 8,604,000USD | 1,206,000USD | 3,844,000USD | -611,000USD | 10,249,000USD | 2,936,000USD | 1,092,000USD |
| Unclassified Investing Cash Flow | — | — | 89,681,000USD | — | — | — | 2,217,325USD | 2,250,300USD |
| Change To Liabilities | — | — | — | -618,000USD | -2,538,000USD | 5,890,000USD | 1,066,000USD | 248,000USD |
| Sale Purchase Of Stock | — | — | — | 29,140,000USD | — | 459,335,000USD | 108,165,000USD | 132,172,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -38,870,000USD | -234,821,000USD | 299,568,000USD | 10,016,000USD | 4,686,000USD |
| Other Cashflows From Investing Activities | — | — | — | 33,253USD | -125,688USD | -97,765USD | -46,325USD | -79,300USD |
| Unclassified Operating Cash Flow | — | — | — | — | 4,603,000USD | — | 1,103,000USD | -1,437,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Collaboration Revenue — Development Services For Monotherapy | 7,200,000 | USD | 0001193125-26-219481 |
| Q1 2026Quarterly · 2026-03-31 | Product | Collaboration Revenue — Development Services In Combination With Other Therapies | 5,300,000 | USD | 0001193125-26-219481 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product | 5,766,000 | USD | 0001193125-26-219481 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.